Quick Takeaways
- Psyence Group Inc. filed SCHEDULE 13D/A for Psyence Biomedical Ltd. Common Shares, without par value (PBM).
- Disclosed ownership: 0%.
- Date of event: 02 May 2025.
Psyence Group Inc. - 02 May 2025 SCHEDULE 13D/A Report for Psyence Biomedical Ltd. Common Shares, without par value (PBM)
- Filing Manager
- Psyence Group Inc.
- Reporting Manager
- Psyence Group Inc.
- Symbol
- PBM
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13D/A
- Filing time
- 12 May 2025, 16:08:16 UTC
- Date of event
- 02 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Psyence Group Inc. disclosed 0% ownership in Psyence Biomedical Ltd. Common Shares, without par value (PBM) on 02 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 May 2025, 16:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Psyence Group Inc. | 0% | 0 | 0 | 0 | /s/ Adri Both | Adri Botha/CEO | 0002009573 |